SE8902624D0 - New pharmaceutical preparations - Google Patents

New pharmaceutical preparations

Info

Publication number
SE8902624D0
SE8902624D0 SE8902624A SE8902624A SE8902624D0 SE 8902624 D0 SE8902624 D0 SE 8902624D0 SE 8902624 A SE8902624 A SE 8902624A SE 8902624 A SE8902624 A SE 8902624A SE 8902624 D0 SE8902624 D0 SE 8902624D0
Authority
SE
Sweden
Prior art keywords
pharmaceutical preparations
new pharmaceutical
psoriasis
new
treatment
Prior art date
Application number
SE8902624A
Other languages
English (en)
Other versions
SE464167B (sv
SE8902624L (sv
Inventor
K Leander
Original Assignee
Analytecon Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Analytecon Sa filed Critical Analytecon Sa
Priority to SE8902624A priority Critical patent/SE464167B/sv
Publication of SE8902624D0 publication Critical patent/SE8902624D0/sv
Priority to AT90911870T priority patent/ATE158948T1/de
Priority to KR1019920700216A priority patent/KR0145678B1/ko
Priority to ES90911870T priority patent/ES2109237T3/es
Priority to JP2510950A priority patent/JP3034026B2/ja
Priority to SU925011143A priority patent/RU2097032C1/ru
Priority to AU60616/90A priority patent/AU633949B2/en
Priority to HU9215A priority patent/HU207939B/hu
Priority to DE69031569T priority patent/DE69031569T2/de
Priority to EP90911870A priority patent/EP0587554B1/en
Priority to DK90911870.5T priority patent/DK0587554T3/da
Priority to PCT/SE1990/000492 priority patent/WO1991001717A1/en
Priority to CA002064476A priority patent/CA2064476C/en
Publication of SE8902624L publication Critical patent/SE8902624L/sv
Publication of SE464167B publication Critical patent/SE464167B/sv
Priority to GB9200158A priority patent/GB2250437B/en
Priority to NO920255A priority patent/NO179632C/no
Priority to FI920428A priority patent/FI100769B/sv
Priority to US08/127,121 priority patent/US6440428B1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
SE8902624A 1989-07-31 1989-07-31 Topisk farmaceutisk beredning av podophyllotoxin SE464167B (sv)

Priority Applications (17)

Application Number Priority Date Filing Date Title
SE8902624A SE464167B (sv) 1989-07-31 1989-07-31 Topisk farmaceutisk beredning av podophyllotoxin
CA002064476A CA2064476C (en) 1989-07-31 1990-07-17 Podophyllotoxin preparation containing triglycerides
DE69031569T DE69031569T2 (de) 1989-07-31 1990-07-17 Podophyllotoxinzubereitung enthaltend triglyceride
DK90911870.5T DK0587554T3 (da) 1989-07-31 1990-07-17 Podofyllotoksinpræparat indeholdende triglycerider
ES90911870T ES2109237T3 (es) 1989-07-31 1990-07-17 Preparacion de podofilotoxina conteniendo trigliceridos.
JP2510950A JP3034026B2 (ja) 1989-07-31 1990-07-17 新規な製剤
SU925011143A RU2097032C1 (ru) 1989-07-31 1990-07-17 Фармацевтический препарат в форме крема
AU60616/90A AU633949B2 (en) 1989-07-31 1990-07-17 A podophyllotoxin preparation containing triglycerides
HU9215A HU207939B (en) 1989-07-31 1990-07-17 Process for producing podofillotoxin composition containing triglicereides
AT90911870T ATE158948T1 (de) 1989-07-31 1990-07-17 Podophyllotoxinzubereitung enthaltend triglyceride
EP90911870A EP0587554B1 (en) 1989-07-31 1990-07-17 A podophyllotoxin preparation containing triglycerides
KR1019920700216A KR0145678B1 (ko) 1989-07-31 1990-07-17 트리글리세라이드를 함유하는 포도필로톡신 제제
PCT/SE1990/000492 WO1991001717A1 (en) 1989-07-31 1990-07-17 A podophyllotoxin preparation containing triglycerides
GB9200158A GB2250437B (en) 1989-07-31 1992-01-06 A podophyllotoxin preparation containing triglycerides
NO920255A NO179632C (no) 1989-07-31 1992-01-20 Fremgangsmåte for fremstilling av et farmasöytisk preparat som inneholder podofyllotoksin
FI920428A FI100769B (sv) 1989-07-31 1992-01-30 Förfarande för framställning av en farmaceutisk podophyllotoxinberedni ng innehållande triglycerider
US08/127,121 US6440428B1 (en) 1989-07-31 1993-09-27 Podophyllotoxin preparation containing triglycerides

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE8902624A SE464167B (sv) 1989-07-31 1989-07-31 Topisk farmaceutisk beredning av podophyllotoxin

Publications (3)

Publication Number Publication Date
SE8902624D0 true SE8902624D0 (sv) 1989-07-31
SE8902624L SE8902624L (sv) 1991-02-01
SE464167B SE464167B (sv) 1991-03-18

Family

ID=20376598

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8902624A SE464167B (sv) 1989-07-31 1989-07-31 Topisk farmaceutisk beredning av podophyllotoxin

Country Status (17)

Country Link
US (1) US6440428B1 (sv)
EP (1) EP0587554B1 (sv)
JP (1) JP3034026B2 (sv)
KR (1) KR0145678B1 (sv)
AT (1) ATE158948T1 (sv)
AU (1) AU633949B2 (sv)
CA (1) CA2064476C (sv)
DE (1) DE69031569T2 (sv)
DK (1) DK0587554T3 (sv)
ES (1) ES2109237T3 (sv)
FI (1) FI100769B (sv)
GB (1) GB2250437B (sv)
HU (1) HU207939B (sv)
NO (1) NO179632C (sv)
RU (1) RU2097032C1 (sv)
SE (1) SE464167B (sv)
WO (1) WO1991001717A1 (sv)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
USRE39494E1 (en) * 1992-02-27 2007-02-27 Intervet Inc. Inactivated mycoplasma hyopneumoniae and uses therefor
AU1761197A (en) 1997-02-14 1998-09-08 Elisabeth Streels Composition with base of coconut oil and its use
FI105152B (sv) 1998-07-17 2000-06-30 Eero Saarela Lokalt smärtlindringsförfarande
SE0102168D0 (sv) * 2001-06-19 2001-06-19 Karolinska Innovations Ab New use and new compounds
ES2665342T3 (es) * 2004-03-15 2018-04-25 Meda Ab Formulaciones y métodos para modificadores de la respuesta inmune
CN100427082C (zh) * 2005-08-02 2008-10-22 盛华（广州）医药科技有限公司 羟基苯甲酸酯及其类似物在制备预防和治疗病毒性感染药物中的应用
US9592188B2 (en) 2014-05-22 2017-03-14 Yansong Liu Method of treating or reducing the severity of dermatological conditions

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3826845A (en) * 1969-02-08 1974-07-30 Sankyo Co Ointment base
DE2063896A1 (de) 1970-12-28 1972-07-20 Dynamit Nobel Ag, 5210 Troisdorf Salbengrundlagen auf der Basis von Triglyceriden gesättigter mittelkettiger Fettsäuren und Verfahren zu deren Herstellung
US4235889A (en) * 1979-04-25 1980-11-25 Pharmazeutische Fabrik Evers & Co. Therapeutic agent for the external treatment of psoriasis, tinea and eczemas
US4341783A (en) * 1980-07-31 1982-07-27 Lemmon Company Topical use of dyphylline and dyphylline containing compositions
IL65588A (en) * 1981-07-10 1985-04-30 Orion Yhtymae Oy Pharmaceutical compositions for the treatment of skin
GB8307614D0 (en) * 1983-03-18 1983-04-27 Pharma Medica As Treatment of genital warts
JPS59184135A (ja) * 1983-04-04 1984-10-19 Teijin Ltd グリセリンピログルタミン酸エステル類を含有する医薬品組成物
JPS6160620A (ja) * 1984-09-03 1986-03-28 Teijin Ltd ピログルタミン酸エステル類を含有する医薬品組成物
JPH0720966B2 (ja) 1984-12-28 1995-03-08 コンプハルム・エイビ− 製薬学的に活性な化合物を含有する病気治療剤
US4895727A (en) 1985-05-03 1990-01-23 Chemex Pharmaceuticals, Inc. Pharmaceutical vehicles for exhancing penetration and retention in the skin
US4751075A (en) * 1986-01-08 1988-06-14 Redken Laboratories, Inc. Anhydrous cosmetic compositions for thermal skin treatments
DE3603859A1 (de) * 1986-02-07 1987-08-13 Roehm Pharma Gmbh Abwaschbare topische zubereitung zur therapie der psoriasis
US4837019A (en) * 1986-08-11 1989-06-06 Charles Of The Ritz Group Ltd. Skin treatment composition and method for treating burned skin
US4863970A (en) * 1986-11-14 1989-09-05 Theratech, Inc. Penetration enhancement with binary system of oleic acid, oleins, and oleyl alcohol with lower alcohols
US4994496A (en) * 1987-09-09 1991-02-19 Repasky Elizabeth A Use of milk globules as carriers for drugs
US5104656A (en) * 1989-06-16 1992-04-14 Seth Pyare L Percutaneous treatment with a high potency non-steroidal anti-inflammatory agent

Also Published As

Publication number Publication date
ATE158948T1 (de) 1997-10-15
SE464167B (sv) 1991-03-18
FI100769B (sv) 1998-02-27
CA2064476A1 (en) 1991-02-01
GB2250437A (en) 1992-06-10
HU9200015D0 (en) 1992-03-30
EP0587554A1 (en) 1994-03-23
GB2250437B (en) 1993-05-26
FI920428A0 (fi) 1992-01-30
NO179632C (no) 1996-11-20
KR920703047A (ko) 1992-12-17
DK0587554T3 (da) 1997-10-27
DE69031569D1 (de) 1997-11-13
JP3034026B2 (ja) 2000-04-17
EP0587554B1 (en) 1997-10-08
NO179632B (no) 1996-08-12
AU6061690A (en) 1991-03-11
HU207939B (en) 1993-07-28
DE69031569T2 (de) 1998-02-19
JPH05500661A (ja) 1993-02-12
NO920255D0 (no) 1992-01-20
KR0145678B1 (ko) 1998-08-17
WO1991001717A1 (en) 1991-02-21
AU633949B2 (en) 1993-02-11
SE8902624L (sv) 1991-02-01
NO920255L (no) 1992-01-20
GB9200158D0 (en) 1992-03-11
US6440428B1 (en) 2002-08-27
ES2109237T3 (es) 1998-01-16
RU2097032C1 (ru) 1997-11-27
CA2064476C (en) 2000-09-12
HUT58996A (en) 1992-04-28

Similar Documents

Publication Publication Date Title
NO871408L (no) Forbedringer ved farmasoeytiske akseptable salter.
ES2140565T3 (es) Nuevos derivados de pirazina-carboxamida, su preparacion y su utilizacion en medicamentos.
MX9203167A (es) Composicion farmaceutica con actividad analgesica.
IT1203743B (it) Peptidi e derivati peptidici,loro preparazione e loro impiego come medicamenti
NL193440B (nl) Farmaceutisch preparaat met analgetische werking.
SE8902624D0 (sv) New pharmaceutical preparations
IT8721691A0 (it) Derivati dell'ossima della 1,2,5,6-tetraidropirdin-3-carbossaldeide, loro procedimento di preparazione e loro impiegocome sostanze medicinali.
ES2062145T3 (es) 1,8-naftiridinas substituidas.
DE3873016T2 (de) Optisch aktive, delta-valerolacton-ring enthaltende verbindung und dieselbe enthaltende fluessigkristalline zusammensetzung.
ES2089286T3 (es) Nuevas 2-amino-5-ciano-1,4-dihidropiridinas, procedimiento para su preparacion y su uso en medicamentos.
DK527487A (da) Farmaceutiske praeparater med forlaenget afgivelse
IT1217352B (it) Palizzata in calcestruzzo nonche'procedimento e dispositivo per laproduzione della stessa.
FI851365L (fi) Liposomer med inhalerbara allergener foer behandling av allergener, foerfarande foer deras framstaellning och dessa innehaollande laekemedel.
DE3877747D1 (de) Glasartige matrize zur verabreichung von heilmitteln.
DE3579074D1 (de) Verminderung der toxischen wirkungen von anthrachinon-medikamenten.
IT8721098A0 (it) Derivati della 1-benzene solfonil 2-oco 5-alchiltio pirrolidina, un loro procedimentodi preparazione e il loro impiegocome stostanze medicinali.
RO94684A2 (ro) Medicament pentru tratamentul unor dermatoze
RO91652A2 (ro) Compozitie medicamentoasa pentru tratamentul unor dermatoze
IT8523406A0 (it) Derivati della 1-benzensolfonil2-osso 5-alcossi pirrolidina, loro procedimento di preparazione e loro impiego come sostanze medicinali.
ATE97802T1 (de) Infusion sauerstoffreicher perfluorierter fluessigkeit im augapfel.
DK163865C (da) Anvendelse af oestrogener til fremstilling af praeparater til lokal anvendelse til behandling af forhoejet tryk i oejet
ATE88342T1 (de) Pharmazeutische zubereitungen zur behandlung der psoriasis, psoriatischen arthritis, neurodermitis und enteritis regionalis crohn.
AU2582588A (en) Pharmaceutical compositions with anti-cancer activity and method for the treatment of cancer

Legal Events

Date Code Title Description
NAL Patent in force

Ref document number: 8902624-9

Format of ref document f/p: F

NUG Patent has lapsed